The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term follow-up results of a phase I/II study of concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma (NKTCL): JCOG0211.
Motoko Yamaguchi
No relevant relationships to disclose
Kensei Tobinai
No relevant relationships to disclose
Masahiko Oguchi
No relevant relationships to disclose
Naoki Ishizuka
No relevant relationships to disclose
Yukio Kobayashi
No relevant relationships to disclose
Yasushi Isobe
No relevant relationships to disclose
Kenichi Ishizawa
No relevant relationships to disclose
Nobuo Maseki
No relevant relationships to disclose
Kuniaki Itoh
No relevant relationships to disclose
Noriko Usui
No relevant relationships to disclose
Izumi Wasada
No relevant relationships to disclose
Satoshi Ishikura
No relevant relationships to disclose
Yoshikazu Kagami
No relevant relationships to disclose
Tomohiro Kinoshita
No relevant relationships to disclose
Tomomitsu Hotta
No relevant relationships to disclose
Kunihiro Tsukasaki
No relevant relationships to disclose
Kazuo Oshimi
Employment or Leadership Position - Eisai